Turning Stem Cells into Clinical Trials

REGISTER HERE for the September Wellness Webcast: Turning Stem Cells into Clinical Trials

What does it take to move stem cell discoveries from the lab into human trials? Join Dr. Marina Emborg, a leader in stem cell neuroscience research, to learn about some important insights from her work in developing and testing stem cell–based approaches for Parkinson’s disease. 

Presenter bio:
Marina Emborg obtained her M.D. and Ph.D. at the University of Buenos Aires and did her postdoctoral training at Somatix Therapy Corp. and The Parkinson’s Institute in Sunnyvale, California. In 2004 she became faculty at the University of Wisconsin, Madison, where today she is the Director of the Preclinical Parkinson’s Research Program at the Wisconsin National Primate Research Center, and the Steenbock Professor of Behavioral and Neural Science in th department of Medical Physics.

Dr. Emborg’s research aims to understand and find solutions for patients with neurodegenerative disorders. She leads a team dedicated to creating platforms for analyzing neurodegeneration across the lifespan, in order to identify biomarkers and treatment targets. Her ability to collaborate and lead multidisciplinary teams from academia and industry has produced foundational studies in disease models, methods of evaluation and therapy delivery.

This webcast is brought you our by platinum sponsor: